Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
16
self-reported 2–10 band
Founded
Not recorded
Legal entities
None matched
Office countries
1
1 address
Funding rounds
3
Grant · Oct 2022 · US$ 10.6K
Company type
Privately Held
self-reported
Description
Veriphi is an innovative medical device company that has developed a solution to verify intravenous drug identity and concentration.
Globally, the cost associated with medication errors has been estimated to be US$42 billion per year. (WHO, Global Patient Safety Challenge: Medication Without Harm, 2017). Veriphi’s initial target market is intravenous oncology errors because intravenous errors are twice as likely to harm patients than drugs administered by other routes.
The heart of our solution is an analyser that uses lasers to verify intravenous drug identity and concentration. Veriphi has been granted 8 US patents and 22 global patents.
The Veriphi solution has applications inside the compounding pharmacy, in hospitals and at the patient’s bedside, wherever that may be.
Our objective is to make intravenous cancer therapy safer, more effective, more affordable and more accessible. We believe that access to cancer treatment should not be dictated by where you live.
Specialties
All 1 specialty
- Drug verification and Medical devices
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | NZ |
All codes: NZ
Addresses
- NZPO Box 32 – 525; Devonport, Auckland 0744Primary
Grid intelligence Members
Funding
Rounds3
Round typeGrant · non-equity funding
Amount (USD)10,600
Stage rank1
Investors named1
Since last round3 yr 2 mo
Funding
Show as table · 3 funding rounds
| Rounds | 3 |
|---|---|
| Axis | 2023 to 2026 |
| Grant · 30 Oct 2022 | US$ 10.6K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
How many people work at Veriphi?
16 counted staff profiles at January 2026, above the self-reported 2–10 band.
Where does Veriphi have offices?
One address on record, New Zealand only. Primary: PO Box 32 – 525, Devonport, Auckland 0744.
Has Veriphi raised funding?
Three rounds. Latest 30 October 2022: grant, US$10,600, investor Callaghan Innovation.
What does Veriphi list as its specialties?
One tag on the brand's own list, among them Drug verification and Medical devices.
Which companies are listed alongside Veriphi?
9 profiles list Veriphi as a peer — 86th percentile in Medical Equipment Manufacturing. It lists ten peers of its own. Intdevice and Endo Sport NZ list it back.